Centrifuge has integrated Symbiotic's Liquid Lane across three tokenized funds representing about $1.6 billion in assets under management, giving eligible holders a new path to exchange positions for USDC immediately.
The integration covers Janus Henderson's JAAA, an AAA-rated collateralized loan obligation strategy, and JTRSY, a short-duration U.S. Treasury strategy. New York Life Investment Management's HYB, a U.S. high-yield corporate bond strategy, is also included.
Symbiotic's Liquid Lane functions as an on-chain request-for-quote marketplace. Market makers access liquidity from vaults to fulfill redemption requests, enabling investors to receive USDC without delay. After acquiring fund tokens through the RFQ marketplace, market makers can redeem them through the original issuer or sell them via another RFQ transaction.
This arrangement allows investors to obtain USDC immediately while the funds' standard redemption processes proceed independently. Centrifuge operates as an asset tokenization and vault platform where asset managers issue and oversee tokenized funds.
Janus Henderson, a global asset manager with approximately $500 billion in assets under management, has been a major contributor to Centrifuge's expansion. Its JAAA and JTRSY products were primary drivers of growth. By December 2025, Centrifuge had attracted about $1.3 billion in new inflows, according to Token Terminal data. JAAA alone contributed around $1 billion in total value locked, establishing itself as one of the largest tokenized funds in the market.
Liquid Lane is not the first liquidity option available for Centrifuge's tokenized funds. Felix Lutsch, Symbiotic's head of ecosystem, said other liquidity routes exist and contribute to a healthy market. Centrifuge previously partnered with Wintermute in February 2025 to offer 24/7 instant redemptions for JTRSY. HYB launched in June with a separate liquidity arrangement for near-instant redemptions.
Lutsch said Liquid Lane's distinction lies in its capital structure rather than speed. The marketplace permits multiple market makers and curators to participate without requiring them to pre-fund and carry inventory for individual assets.
Low trading volumes in tokenized assets have historically constrained market flow and provided minimal incentive for market makers to commit capital, Lutsch said. Aggregating redemption demand across various issuers and asset classes could improve these economics, particularly as tokenized funds see increased use as collateral and financing assets in on-chain markets. Symbiotic is backed by Paradigm, Pantera Capital, cyber•Fund and Coinbase Ventures.
